Ankit Kumar Singh

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 8

Top Topics

Epidermal Growth Factor Receptor

Molecular Docking

Structure Activity Relationship

Top Venues

Journal of biomolecular structure & dynamics

Pharmaceuticals (Basel, Switzerland)

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Teja Ram, Ankit Kumar Singh, Prateek Pathak, Adarsh Kumar, Harshwardhan Singh, Maria Grishina, Jurica Novak, Pradeep Kumar
Design, one-pot synthesis, computational and biological evaluation of diaryl benzimidazole derivatives as MEK inhibitors. Journal of biomolecular structure & dynamics (2023)
Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja Angre, Amita Verma, Habibullah Khalilullah, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Pradeep Kumar
Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents. RSC advances 13 (10) (2023)
Priyanka Bajpai, Ankit Kumar Singh, Shivanada Kandagalla, Phool Chandra, Vimlendu Kumar Sah, Pradeep Kumar, Maria Grishina, Om Prakash Verma, Prateek Pathak
Oxazoline/amide derivatives against M. tuberculosis : experimental, biological and computational investigations. Journal of biomolecular structure & dynamics (2023)
Teja Ram, Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Prateek Pathak, Maria Grishina, Habibullah Khalilullah, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Amita Verma, Pradeep Kumar
MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives. RSC medicinal chemistry 14 (10) (2023)
Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria A Grishina, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid M Emwas, Pradeep Kumar
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Adarsh Kumar, Kuber Kumar Bhagat, Ankit Kumar Singh, Harshwardhan Singh, Tanuja Angre, Amita Verma, Habibullah Khalilullah, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Pradeep Kumar
Medicinal chemistry perspective of pyrido[2,3- d ]pyrimidines as anticancer agents. RSC advances 13 (10) (2023)
Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Harshali Paliwal, Suresh Thareja, Prateek Pathak, Maria A Grishina, Mariusz Jaremko, Abdul-Hamid M Emwas, Jagat Pal Yadav, Amita Verma, Habibullah Khalilullah, Pradeep Kumar
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids. Pharmaceuticals (Basel, Switzerland) 15 (9) (2022)
Ankit Kumar Singh, Jurica Novak, Adarsh Kumar, Harshwardhan Singh, Suresh Thareja, Prateek Pathak, Maria Grishina, Amita Verma, Jagat Pal Yadav, Habibullah Khalilullah, Vikas Pathania, Hemraj Nandanwar, Benjamin Gabriel Poulson, Abdul-Hamid Emwas, Pradeep Kumar
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine-sulfonamide hybrids as selective BRAF V600E inhibitors. RSC advances 12 (46) (2022)